On Jan 7, 2013, Dr. Chen Chunlin, CEO, will attended the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, USA. The conference has a high degree of recognition n the biopharmaceutical industry. A lot of investors and corporate CEO attend the meeting.
Medicilon has been recognized as one of the top drug discovery contract research organizations (CRO) in China